Investigating the Heterogeneity of Immune Cells in Triple-Negative Breast Cancer at the Single-Cell Level before and after Paclitaxel Chemotherapy

Despite the numerous treatments for triple-negative breast cancer (TNBC), chemotherapy is still one of the most effective methods. However, the impact of chemotherapy on immune cells is not yet clear. Therefore, this study aims to explore the different roles of immune cells and their relationship wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Heng, Lin, Zhang, Zhang, Yangfan, Liu, Jingjing, Chen, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532302/
https://www.ncbi.nlm.nih.gov/pubmed/37762493
http://dx.doi.org/10.3390/ijms241814188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532302/
https://www.ncbi.nlm.nih.gov/pubmed/37762493
http://dx.doi.org/10.3390/ijms241814188

Ejemplares similares